TAMIFLU® or oseltamivir phosphate as its generic name is FDA-approved to treat and prevent influenza. The following article contains informations about TAMIFLU® that may be helpfull for healthcare providers in case you have been asked to give TAMIFLU® to people who have been exposed to H1N1 influenza.

It consists of sections such recommended treatment and prophylaxis dosage for adults and adolescents 13 years and older, pediatric patients older than 1 year old, pediatric patients less than 1 year old, dosage instruction for special conditions, and preparations of TAMIFLU® for Oral Suspension. The description of dosage recommendations are shown in the table of each sections.

You can find TAMIFLU® an FDA Recommendation for Treatment and Prophylaxis in this page with this link to download its pdf filetype (source: fda.gov, image: dbtechno.com).